menu shortcut
contents shortcut
What's new
no
title
date
26
SK Biopharmaceuticals Announces U.S. FDA's Authorization of IND for SKL15508
2013.04.17
25
SK Biopharmaceuticals Enters into a Strategic Alliance with SK Chemicals
2013.04.08
24
SK Biopharmaceuticals Announces a Strategic Alliance for Innovative Drug Development with Chinese Biopharmaceutical Companies
2013.03.26
23
SK Biopharmaceuticals Drug Program is Granted Funding Support from Korean Government
2012.12.13
22
SK Biopharmaceuticals Enters into a Licensing Agreement with Hanmi Pharmaceutical
2012.05.03
21
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
2012.03.19
20
SK Bio-Pharmaceuticals Announces New CEO, Dr. Christopher Gallen
2012.03.06
19
SK Biopharmaceuticals Drug Program Wins Funding Support from Korean Government
2012.03.02
18
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
2012.02.22
17
SK biopharmaceuticals Enters into a Licensing Agreement with Premier Chinese Biopharmaceutical Company
2011.11.02
1
.
2
.
3
Pipeline Products
YKP509
YKP3089
SKL-NP
SKL-NO5
YKP1447
SKL-DEP
YKP-GI
SKL-PD
SKL-PSY